Tuesday, June 16, 2026

Chong Kun Dang Bets on R&D, Manufacturing and Financing to Strengthen Global Pharma Ambitions

Chong Kun Dang is enhancing R&D and manufacturing to boost global competitiveness, investing $286M in a new research complex.

K-Bio Targets the U.S. Market: Celltrion and Samsung Bioepis Close in on Originator Drugs

Celltrion and Samsung Bioepis are expanding in the U.S. market, showing strong growth in biosimilars like Zymfentra and Hadlima.

Amid Rising Drug Resistance, Korea Begins DOMINO Trial to Reassess First-Line Treatment for Pediatric Mycoplasma

The DOMINO trial will assess treatments for pediatric Mycoplasma pneumonia, addressing rising macrolide resistance in Korea.

Tag: Gumi plant

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

LG Chem Eyes China-Free Supply Chain to Avoid FEOC Designation

LG Chem is considering adjusting its stake in a Gumi plant due to U.S. regulations, aiming for a China-free supply chain.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.